Review article: anti‐adhesion therapies for inflammatory bowel disease von Lobatón, T., Vermeire, S., Assche, G., Rutgeerts, P.

Volltext

Review article: infliximab therapy for inflammatory bowel disease – seven years on von RUTGEERTS, P., ASSCHE, G., VERMEIRE, S.

Volltext

An expert consensus to standardise definitions, diagnosis and treatment targets for anti‐fibrotic stricture therapies in Crohn's disease von Rieder, F., Bettenworth, D., Ma, C., Parker, C. E., Williamson, L. A., Nelson, S. A., van Assche, G., Di Sabatino, A., Bouhnik, Y., Stidham, R. W., Dignass, A., Rogler, G., Taylor, S. A., Stoker, J., Rimola, J., Baker, M. E., Fletcher, J. G., Panes, J., Sandborn, W. J., Feagan, B. G., Jairath, V.

Volltext

Laboratory markers in IBD: useful, magic, or unnecessary toys? von Vermeire, S, Van Assche, G, Rutgeerts, P

Volltext

Short‐ and medium‐term outcomes following primary ileocaecal resection for Crohn's disease in two specialist centres von de Buck van Overstraeten, A., Eshuis, E. J., Vermeire, S., Van Assche, G., Ferrante, M., D'Haens, G. R., Ponsioen, C. Y., Belmans, A., Buskens, C. J., Wolthuis, A. M., Bemelman, W. A., D'Hoore, A.

Volltext

Efficacy and safety of anti‐TNF therapy in elderly patients with inflammatory bowel disease von Lobatón, T., Ferrante, M., Rutgeerts, P., Ballet, V., Van Assche, G., Vermeire, S.

Volltext

Long-term safety of infliximab for the treatment of inflammatory bowel disease: a single-centre cohort study von Fidder, H, Schnitzler, F, Ferrante, M, Noman, M, Katsanos, K, Segaert, S, Henckaerts, L, Van Assche, G, Vermeire, S, Rutgeerts, P

Volltext

The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management von Dignass, A., Van Assche, G., Lindsay, J.O., Lémann, M., Söderholm, J., Colombel, J.F., Danese, S., D'Hoore, A., Gassull, M., Gomollón, F., Hommes, D.W., Michetti, P., O'Morain, C., Öresland, T., Windsor, A., Stange, E.F., Travis, S.P.L.

Volltext

Reaction mechanism, kinetics and high temperature transformations of geopolymers von Rahier, H., Wastiels, J., Biesemans, M., Willlem, R., Van Assche, G., Van Mele, B.

Volltext

Imaging techniques for assessment of inflammatory bowel disease: Joint ECCO and ESGAR evidence-based consensus guidelines von Panes, J., Bouhnik, Y., Reinisch, W., Stoker, J., Taylor, S.A., Baumgart, D.C., Danese, S., Halligan, S., Marincek, B., Matos, C., Peyrin-Biroulet, L., Rimola, J., Rogler, G., van Assche, G., Ardizzone, S., Ba-Ssalamah, A., Bali, M.A., Bellini, D., Biancone, L., Castiglione, F., Ehehalt, R., Grassi, R., Kucharzik, T., Maccioni, F., Maconi, G., Magro, F., Martín-Comín, J., Morana, G., Pendsé, D., Sebastian, S., Signore, A., Tolan, D., Tielbeek, J.A., Weishaupt, D., Wiarda, B., Laghi, A.

Volltext

Mucosal gene signatures to predict response to infliximab in patients with ulcerative colitis von Arijs, I, Li, K, Toedter, G, Quintens, R, Van Lommel, L, Van Steen, K, Leemans, P, De Hertogh, G, Lemaire, K, Ferrante, M, Schnitzler, F, Thorrez, L, Ma, K, Song, X-Y R, Marano, C, Van Assche, G, Vermeire, S, Geboes, K, Schuit, F, Baribaud, F, Rutgeerts, P

Volltext

Review article: non-malignant haematological complications of anti-tumour necrosis factor alpha therapy von Bessissow, T., Renard, M., Hoffman, I., Vermeire, S., Rutgeerts, P., Van Assche, G.

Volltext

Anti‐infliximab antibody concentrations can guide treatment intensification in patients with Crohn's disease who lose clinical response von Dreesen, E., Van Stappen, T., Ballet, V., Peeters, M., Compernolle, G., Tops, S., Van Steen, K., Van Assche, G., Ferrante, M., Vermeire, S., Gils, A.

Volltext

Optimizing anti-TNF treatment in inflammatory bowel disease von Rutgeerts, Paul, van Assche, Gert, Vermeire, Séverine

Volltext

Quantum distribution of Gaussian keys using squeezed states von Cerf, N. J., Lévy, M., Assche, G. Van

Volltext

Long-term outcome of patients with steroid-refractory acute severe UC treated with ciclosporin or infliximab von Laharie, D, Bourreille, A, Branche, J, Allez, M, Bouhnik, Y, Filippi, J, Zerbib, F, Savoye, G, Vuitton, L, Moreau, J, Amiot, A, Cosnes, J, Ricart, E, Dewit, O, Lopez-Sanroman, A, Fumery, M, Carbonnel, F, Bommelaer, G, Coffin, B, Roblin, X, van Assche, G, Esteve, M, Farkkila, M, Gisbert, JP, Marteau, P, Nahon, S, de Vos, M, Lambert, J, Mary, JY, Louis, E

Volltext

A self-healing polymer network based on reversible covalent bonding von Scheltjens, G., Diaz, M.M., Brancart, J., Van Assche, G., Van Mele, B.

Volltext

Room-temperature versus heating-mediated healing of a Diels-Alder crosslinked polymer network von Diaz, M.M., Brancart, J., Van Assche, G., Van Mele, B.

Volltext

Long-term outcome of treatment with infliximab in 614 patients with Crohn’s disease: results from a single-centre cohort von Schnitzler, F, Fidder, H, Ferrante, M, Noman, M, Arijs, I, Van Assche, G, Hoffman, I, Van Steen, K, Vermeire, S, Rutgeerts, P

Volltext

Prior response to infliximab and early serum drug concentrations predict effects of adalimumab in ulcerative colitis von Baert, F., Vande Casteele, N., Tops, S., Noman, M., Van Assche, G., Rutgeerts, P., Gils, A., Vermeire, S., Ferrante, M.

Volltext